Navigation Links
Oridion Signs Strategic Development and Marketing Agreement with Global Healthcare Company
Date:1/14/2009

Oridion Microstream(R) Technology to be Incorporated Into Market Leader's Patient-Controlled Analgesia (PCA) Device

JERUSALEM and NEEDHAM, Massachusetts, January 15 /PRNewswire-FirstCall/ -- Oridion Systems Ltd. (SIX Swiss Exchange: ORIDN) today announced an agreement with a global healthcare company that is a market leader in medication infusion systems. Under this agreement, Oridion's Capnostream(TM) carbon dioxide (CO2) monitor using Microstream(R) capnography technology will be incorporated into a PCA infusion device at a future date, allowing hospital patients to control the flow of their pain medication within specified limits.

By enabling connectivity between the Capnostream and PCA device, clinicians will be able to monitor their patients' end tidal (CO2) levels. Clinicians using Microstream are more likely to detect respiratory depression than clinicians monitoring with pulse oximetry alone.(1) This is particularly important when administering potent pain medication.

The ability to monitor CO2 levels is vital. It can alert clinicians to episodes of hypoventilation as well as help them assess ventilation and treatment of asthma and chronic obstructive pulmonary disease (COPD) in patients. This is the reason why organizations, such as the Anesthesia Patient Safety Foundation (APSF)(2) and the American Society of Anesthesiologists (ASA)(3) recommend ventilatory monitoring when administering opiates and during procedural sedation. Patient-controlled analgesia systems are used in both environments.

"More and more hospital systems are becoming proactive about instituting policies to assure patient safety when potent drugs are used," said Gerry Feldman, president of Oridion. "It is good to see that the hospital community recognizes the importance of monitoring ventilation effectively, a necessity to safely eliminate unnecessary patient pain, a Joint Commission mandate. Our newest partner has selected Oridion, the world-wide leader in capnography monitoring, as an additional important step in their commitment to help hospitals reduce medication errors, improve patient safety and adhere to best clinical practices."

Further details regarding this agreement were not disclosed.

About Oridion

Oridion Systems Ltd. (http://www.oridion.com) is a global medical device company specializing in patient safety monitoring. The Company operates through wholly owned subsidiaries in the United States, Europe, and Israel.

Oridion develops proprietary medical devices and patient interfaces, based on its patented Microstream(R) technologies, for the enhancement of patient safety through the monitoring of the carbon dioxide (CO2) in a patient's breath. These products provide effective, proven airway management and are used in various clinical environments, including procedural sedation, pain management, operating rooms, critical care units, post-anesthesia care units, emergency medical services, transport, alternate care and other settings where patients' ventilation may be compromised and at risk.

(1) Jonathan B. Waugh, PhD, RRT, RPFT; Yulia Khodneva, MD; Chad A. Epps, MD, Monitoring to Improve Ventilation Safety during Sedation and Analgesia. Society for Technology in Anesthesia 2008.

(2) Anesthesia Patient Safety Foundation (APSF) Newsletter, Winter 2006-2007, Vol. 21, 4.

(3) American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 2002; 96(4):1004-17.

    For further Oridion information please contact:

    Alan Adler, Chairman and Chief Executive Officer,
    Walter Tabachnik, Chief Financial Officer,
    Elena Gerberg, Investor Relations;

    e-mail: investor@oridion.com ,
    website:http://www.oridion.com ,
    phone: +972-2-589-9159,
    address: Oridion Systems Ltd., P.O. Box 45025, 91450 Jerusalem, Israel.



'/>"/>
SOURCE Oridion Systems Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Oridion Introduces New Smart Capnography System for Improved Patient Safety
2. Pot bellies linked to early signs of cardiovascular disease
3. MSU engineering team designs innovative medical device
4. Jump in Youth Suicide Prompts National Childrens Charity KidsPeace to Issue Tips on Prevention, Warning Signs
5. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
6. Gov. Blagojevich Signs Bill Improving Illinois Mental Illness Treatment Law
7. A new technology for cancer screening listens for the signs of cancer
8. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
9. Pearson VUE Signs Exclusive Contract with Educational Resources, Inc.
10. Former Ronco President Tim Dupler Signs International Direct Sales and Marketing Contract with Natural Nutrition
11. KARL LAGERFELD SAS Signs Global Eyewear License Agreement With Marchon Eyewear, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: